UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer

Cancer, 2009-04, Vol.115 (8), p.1701-1712

2009

Volltextzugriff (PDF)

mTOR Signaling Pathway and mTOR Inhibitors in Cancer Therapy

Hematology/oncology clinics of North America, 2012-06, Vol.26 (3), p.483-505

2012

Volltextzugriff (PDF)

Induction of bicalutamide sensitivity in prostate cancer cells by an epigenetic Purα-mediated decrease in androgen receptor levels

The Prostate, 2010-02, Vol.70 (2), p.179-189

2010

Volltextzugriff (PDF)

Vascular Endothelial Growth Factor (VEGF) Serum Levels Are Associated With Survival in Early Stages of Lung Cancer Patients

Cancer investigation, 2010-05, Vol.28 (4), p.393-398

2010

Volltextzugriff (PDF)

Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer

Clinical cancer research, 2019-01, Vol.25 (1), p.52-63

2019

Volltextzugriff (PDF)

Phase 1/2 study of the novel SUMOylation inhibitor TAK-981 in adult patients (pts) with advanced or metastatic solid tumors or relapsed/refractory (RR) hematologic malignancies

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS2667-TPS2667

2021

Volltextzugriff (PDF)

A Phase 1b/2 Study of TAK-981, a First-in-Class Sumoylation Inhibitor, in Combination with Rituximab in Patients with Relapsed/Refractory (r/r) CD20-Positive Non-Hodgkin Lymphoma (NHL)

Blood, 2019-11, Vol.134 (Supplement_1), p.1593-1593

2019

Volltextzugriff (PDF)

A phase 1b, multicenter, dose-escalation study of subasumstat (TAK-981) in combination with pembrolizumab in patients (pts) with advanced solid tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2506-2506

2022

Volltextzugriff (PDF)

TAK-981, a First-in-Class SUMO-Activating Enzyme Inhibitor, Combined with Rituximab in Adult Patients (Pts) with CD20-Positive Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL): Phase 1 Data

Blood, 2021-11, Vol.138 (Supplement 1), p.2488-2488

2021

Volltextzugriff (PDF)

Influencing cancer treatment

The lancet oncology, 2015-12, Vol.16 (16), p.1591-1593

2015

Volltextzugriff (PDF)

Correction: Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer

Clinical cancer research, 2019-04, Vol.25 (8), p.2672-2672

2019

Volltextzugriff (PDF)

Effect of enzalutamide (EZ) exposure time on androgen receptor (AR) splice variant (SV) expression and gene transcription correlates in androgen-dependent (AD) prostate cancer (PC) cells

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e22066-e22066

2014

Volltextzugriff (PDF)

mTOR Signaling Pathway and mTOR Inhibitors in Cancer Therapy: New Drugs for Malignancy

Hematology/oncology clinics of North America, 2012, Vol.26 (3)

2012

Volltextzugriff (PDF)

Effect of inhibition of the PI3K/Akt/mTOR pathway on AR splicing and downstream targets

Journal of clinical oncology, 2013-02, Vol.31 (6_suppl), p.101-101

2013

Volltextzugriff (PDF)

KLF6 Loss of Function in Human Prostate Cancer Progression Is Implicated in Resistance to Androgen Deprivation

The American journal of pathology, 2012-09, Vol.181 (3), p.1007-1016

2012

Volltextzugriff (PDF)

Vascular Endothelial Growth Factor (VEGF) Serum Levels Are Associated With Survival in Early Stages of Lung Cancer Patients

Cancer investigation, 2010-04, Vol.28 (4), p.393-398

2010

Volltextzugriff (PDF)

Evaluation of Docetaxel, Cisplatin and Capecitabine (DCX) as Perioperative Chemotherapy for Resectable Gastric and Esophago-Gastric Cancer

Annals of oncology, 2014-06, Vol.25, p.ii26-ii26

2014

Volltextzugriff (PDF)

Alternative splicing of Krüppel-like factor 6 (KLF6) enriched in human androgen-deprived prostate cancer (PC)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e15191-e15191

2012

Volltextzugriff (PDF)

Immunotherapy in the treatment of advanced prostate cancer

Canadian journal of urology, 2011-10, Vol.18 (5), p.5865

2011

Volltextzugriff (PDF)

Induction of bicalutamide sensitivity in prostate cancer cells by an epigenetic Puralpha-mediated decrease in androgen receptor levels

The Prostate, 2010-02, Vol.70 (2), p.179-189

2010

Volltextzugriff (PDF)

Effectiveness of a Patient-Centered Assessment With a Solution-Focused Approach (DIALOG-A) in the Routine Care of Colombian Adolescents With Depression and Anxiety: Protocol for a Multicenter Cluster Randomized Controlled Trial

JMIR research protocols, 2023-02, Vol.12, p.e43401-e43401

2023

Volltextzugriff (PDF)

Prevalence and clinical features of psoriatic arthritis in psoriasis patients in Spain. Limitations of PASE as a screening tool

EJD. European journal of dermatology, 2015, Vol.25 (1), p.57-63

2015

Volltextzugriff (PDF)

Intoxicaciones agudas: perfil epidemiológico y clínico, y análisis de las técnicas de descontaminación digestiva utilizadas en los servicios de urgencias españoles en el año 2006 ¿Estudio HISPATOX

Emergencias, 2008, Vol.20 (1), p.15-26

2008

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(23)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer

mTOR Signaling Pathway and mTOR Inhibitors in Cancer Therapy

Induction of bicalutamide sensitivity in prostate cancer cells by an epigenetic Purα-mediated decrease in androgen receptor levels

Vascular Endothelial Growth Factor (VEGF) Serum Levels Are Associated With Survival in Early Stages of Lung Cancer Patients

Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer

Phase 1/2 study of the novel SUMOylation inhibitor TAK-981 in adult patients (pts) with advanced or metastatic solid tumors or relapsed/refractory (RR) hematologic malignancies

A Phase 1b/2 Study of TAK-981, a First-in-Class Sumoylation Inhibitor, in Combination with Rituximab in Patients with Relapsed/Refractory (r/r) CD20-Positive Non-Hodgkin Lymphoma (NHL)

A phase 1b, multicenter, dose-escalation study of subasumstat (TAK-981) in combination with pembrolizumab in patients (pts) with advanced solid tumors

TAK-981, a First-in-Class SUMO-Activating Enzyme Inhibitor, Combined with Rituximab in Adult Patients (Pts) with CD20-Positive Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL): Phase 1 Data

Influencing cancer treatment

Correction: Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer

Effect of enzalutamide (EZ) exposure time on androgen receptor (AR) splice variant (SV) expression and gene transcription correlates in androgen-dependent (AD) prostate cancer (PC) cells

mTOR Signaling Pathway and mTOR Inhibitors in Cancer Therapy: New Drugs for Malignancy

Effect of inhibition of the PI3K/Akt/mTOR pathway on AR splicing and downstream targets

KLF6 Loss of Function in Human Prostate Cancer Progression Is Implicated in Resistance to Androgen Deprivation

Vascular Endothelial Growth Factor (VEGF) Serum Levels Are Associated With Survival in Early Stages of Lung Cancer Patients

Evaluation of Docetaxel, Cisplatin and Capecitabine (DCX) as Perioperative Chemotherapy for Resectable Gastric and Esophago-Gastric Cancer

Alternative splicing of Krüppel-like factor 6 (KLF6) enriched in human androgen-deprived prostate cancer (PC)

Immunotherapy in the treatment of advanced prostate cancer

Induction of bicalutamide sensitivity in prostate cancer cells by an epigenetic Puralpha-mediated decrease in androgen receptor levels

Effectiveness of a Patient-Centered Assessment With a Solution-Focused Approach (DIALOG-A) in the Routine Care of Colombian Adolescents With Depression and Anxiety: Protocol for a Multicenter Cluster Randomized Controlled Trial

Prevalence and clinical features of psoriatic arthritis in psoriasis patients in Spain. Limitations of PASE as a screening tool

Intoxicaciones agudas: perfil epidemiológico y clínico, y análisis de las técnicas de descontaminación digestiva utilizadas en los servicios de urgencias españoles en el año 2006 ¿Estudio HISPATOX

Suchergebnisse filtern